ADPT Adaptive Biotechnologies Corporation

27.93USD-0.43%Mkt Cap: 4.52B USDP/E: —

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a su…